Mr. Barry Balfe
CEO, ICON Pharma Development Solutions
Pharma Development & Clinical Research Strategy
Executive-only • Curated admission • Limited seats
|
Dates: 20–22 January 2027
|
Venue: Singapore
Executive-only • Translational Medicine • Biotech Innovation • Clinical Strategy
11th Executive Congress on Translational Medicine Biotech Innovation & Clinical Strategy
ECTMBICS 2027 brings together senior leaders from translational medicine, biotechnology, pharmaceutical innovation, clinical research, and healthcare strategy to accelerate the journey from scientific discovery to real-world clinical impact.
Focus Areas: Clinical Translation • Biotech Innovation • Pharma Strategy • Digital Health • Clinical Commercialisation
Venue
Singapore
Global biotech, clinical research, and healthcare innovation hub.
Dates
20–22 January 2027
3-day executive program.
Format
Executive-only
Curated participation for senior researchers, clinicians, biotech leaders, and pharma strategists.
Outcome
Clinical translation & partnerships
Designed to support research translation, clinical adoption, and industry collaboration.
Congress overview
Executive-level dialogue with limited seats. Apply for eligibility review, curated introductions, and strategic participation.
Dates
20–22 January 2027
Location
Singapore
Exact hotel / host venue will be announced shortly
Participation model
Apply → Confirm → Register
Relevance-first access and verified attendance
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Executive Congress Experience
Clinical Translation • Biotech Strategy • Healthcare Innovation
Key dates
Short, clear milestones for proposals and participation.
Proposal submission
31 August 2026
Notification
Within 7–10 days of submission
Early Registration
20 September 2026
Congress dates
20–22 January 2027
Note: The exact Singapore host venue will be published once finalized.
Why senior leaders choose this format
A focused executive cadence built for high-level exchange across translational medicine, biotechnology, clinical research, digital health, pharma strategy, and healthcare commercialisation.
Curated admission
Attendance is relevance-first to protect executive time, scientific quality, and strategic value.
Apply → eligibility review
Clinical strategy dialogue
Structured formats for clinical adoption, regulatory pathways, trial design, and commercial strategy.
Executive-led sessions
Industry–academia collaboration
Connections across universities, hospitals, biotech companies, pharma groups, investors, and innovation hubs.
High-trust networking
Premium support
Invoices, documentation support, delegate assistance, visa-letter guidance, and participation coordination.
Featured Leaders
Senior clinical, translational, and industry leaders shaping evidence generation, implementation pathways, and patient impact.
Prof. Han-Chung Wu
Biomedical Translation Research Center (BioTReC), Taiwan
Biomedical Translation & Therapeutic Innovation
Matthew Hewitt
Charles River Laboratories
Preclinical Development & Translational Research
Prof. Lani Wu
University of California, San Francisco
Translational Medicine & Biomedical Discovery
Dr. Feng-Chi Chen
National Health Research Institutes
Population Health & Clinical Evidence
Marc Goemans
Chief Commercial Officer, Bora Biologics
Biologics Commercialisation & Industry Strategy
Dr. Guillermo Del Angel
Center for Genomics Research, AstraZeneca
Genomics Research & Precision Medicine
Ed Deng
Co-Founder and CEO, Health2Sync
Digital Health & Patient-Centred Innovation
Sanghoon Park
CEO, Illimis Therapeutics, Korea
Therapeutics Innovation & Biotech Leadership
Strategic Partners
ECTMBICS 2027 recognises organisations contributing to translational medicine, biotech innovation, clinical research, digital health, diagnostics, AI healthcare, and industry collaboration.
Armastec
Advanced medical technology and healthcare innovation support for clinical and translational ecosystems.
CancerfreeBio
Precision oncology and translational biotech innovation focused on cancer research and diagnostics.
Gyder
Digital innovation and intelligent systems supporting healthcare, biotech, and research-driven collaboration.
Intermag
Applied technology and innovation partner supporting cross-sector scientific and industry engagement.
Nanotis
Nanotechnology-enabled diagnostics and biomedical innovation aligned with next-generation healthcare.
Qritive
AI-powered pathology and digital diagnostics platform supporting faster clinical decision-making.
VinBrain
AI healthcare and medical imaging innovation advancing clinical intelligence and digital health systems.
Partner with ECTMBICS 2027
Join the executive clinical and biotech innovation network.
Become a Strategic Partner
Connect with clinical, biotech, pharma, digital health, and translational medicine decision-makers.
Explore →Themes & focus areas
Clear themes help delegates assess relevance quickly and support high-quality proposals.
Translational Medicine & Bench-to-Bedside Innovation
Accelerating discovery from laboratory research to clinical application and patient benefit.
Clinical Trials, Regulatory Science & Approvals
Trial design, regulatory pathways, ethics, evidence generation, and approval strategy.
Biotech Innovation & Therapeutics Development
Biologic therapies, advanced therapeutics, biotech platforms, and development pipelines.
Precision Medicine & Genomics
Genomics, biomarkers, companion diagnostics, stratified treatment, and personalised care.
Digital Health, AI & Clinical Decision Systems
AI-enabled diagnostics, decision support, data platforms, remote care, and digital medicine.
Pharma Strategy & Commercialisation
Market access, portfolio strategy, industry partnerships, reimbursement, and clinical adoption.
Biomaterials, Drug Delivery & Advanced Therapies
Novel delivery systems, regenerative platforms, cell therapies, and bioengineered solutions.
Healthcare Systems, Policy & Access
Clinical adoption, health economics, patient access, reimbursement, and system integration.
Industry–Academia Collaboration Models
Partnership models linking universities, hospitals, biotech firms, pharma, investors, and innovation ecosystems.
Agenda at a glance
A clear executive cadence across three days — structured time blocks for keynote dialogue, roundtables, industry exchange, clinical strategy sessions, and partnership outcomes.
Day 01
Opening perspectives
Executive welcome, keynote insights, translational medicine priorities, and innovation ecosystem framing.
Day 02
Clinical strategy & biotech exchange
Focused sessions on clinical trials, regulatory strategy, biotech pipelines, precision medicine, and digital health.
Day 03
Partnership pathways
Collaboration opportunities, commercialisation dialogue, healthcare implementation, and forward-looking conclusions.
How participation works
Our executive model protects relevance and trust. Apply to attend, receive confirmation, then secure participation.
Step 01
Apply to attend
Share role, institution, expertise, and participation objectives.
Step 02
Confirmation
Eligibility review and confirmation email.
Step 03
Secure participation
Invoice support and registration completion.
Need an invoice or quick call?
We can support invoices, participation confirmation, invitation documentation, and visa-letter guidance.
Business Address: 98 Theobalds Rd, London WC1X 8WB, UK
Host location
Venue details, access, and local guidance
Venue & access
The congress will take place in Singapore, a leading Asia-Pacific hub for biotechnology, clinical research, healthcare innovation, and international business connectivity. The exact hotel and host venue details will be announced shortly and shared with all confirmed participants in advance.
City
Singapore
Host venue
To be announced